Brita Belli - nerd translator
@BritaBelli
Senior Communications Manager at Recursion. Writer, reader and fitness lover.
Tomorrow, @scientistsorg and the House R&D Caucus will host a briefing on Capitol Hill: “Make America Great for Science.” It will spotlight the growing brain drain and the assault on the U.S. science workforce. Submit your questions + more info below:
AI has revolutionized image generation, language, and even protein folding. But when it comes to creating new drugs—where lives are literally on the line—the revolution is still a question mark. Why? wired.com/story/artifici…
It's not easy for a reporter to capture the way a company works from the inside -- the people driving it and their motivations. It requires access, transparency, and really sharp storytelling skills. 💥 All of those came together in this @WIRED feature from @vero_greenwood.…
I was explaining to my Ukrainian colleague the phrase ‘There’s no such thing as a free lunch’. She told me the equivalent in Ukrainian is ‘The only free cheese is in the mousetrap’ - which is so much better
This is staggering.
2 weeks without smartphone internet significantly improved sustained attention. The effects were similar to being a decade younger.
A look into the not-so-distant future of coming biotech breakthroughs: George Church on @dwarkeshpodcast. 💡 George Church is an American geneticist, molecular engineer, chemist and foundational figure in the fields of personal genomics and synthetic biology. He’s a professor at…
1/ We are excited to open-source the SynFlowNet-Boltz-2 trainer today! 🧵
x.com/i/article/1938…
Getting to the virtual cell is the holy grail of life science. Now there's a challenge on to accelerate it cell.com/cell/fulltext/… @arcinstitute @CellCellPress @nvidia @10xGenomics @yusufroohani @StanfordAILab @davey_burke @UltimaGenomics
“I’m still the hope guy.” Two nights ago I had the great privilege of taking my daughters to see President @BarackObama in conversation with historian @HC_Richardson at the Bushnell in Hartford. He offered a perspective that only he can on the moment we are in -- how we got…
An excellent example of the importance of how information is communicated -- particularly when it comes to science and medicine. The context and delivery are so, so critical.
"I don't think when you're diagnosed with cancer, it's time for a statistics lesson." Mathematician Hannah Fry on why humans struggle to see the world in probabilities, and how it changes decision-making.
Day 2 at BIO: Computational Drug Design Panel with some iconic people including Derek Lowe, Najat Khan talking about the bottlenecks in clinical trial design, the absence of negative data available in public databases for biochem models to train on
On Tue, 6/17 12pm ET on Zoom 🎦 @pas_saro, @GabriCorso, @jeremyWohlwend will present Boltz-2! Models and careful affinity data handling result in an affinity predictor approaching FEP accuracy at 1000x the speed 🔥 Details: portal.valencelabs.com/starklyspeaking 🗓️RSVP: lu.ma/4bpuwbsr
Thank you everyone for attending the Boltz-2 Boston, San Francisco and Paris events this week! Given the success of the in-person seminars and the many requests, we are organizing a virtual seminar on Tuesday at 12pm ET / 6pm CET! Sign up here: lu.ma/4bpuwbsr
⛈️ Navigating the storm in biotech comms. Last night, I attended a frank and necessary panel discussion for biotech pr and comms folks in NYC hosted by @missionnorth in their NYC office. The panel featured a cross-section of professionals whose careers are impacted by these…
A recent post from @math_rachel, cofounder of fast.ai, raises an interesting point – while training an AI model to predict complex biological functions often receives widespread attention and excitement from the scientific press and community (and sometimes even…
I could not agree more.
Boltz-2 launch pageantry top-tier, every important Bio/ML tool should aspire to this level of attention and PR push (Or even beyond ML, would be cool to see something like this drive adoption of Heng Li’s pangene)
📣 Researchers at @MIT & @RecursionPharma just released the first tool to solve protein binding affinity prediction at scale – a major hurdle in drug discovery. 🚀 Boltz-2 is a powerful tool built on novel machine learning that not only predicts protein structure but protein…
🚀 5 open science initiatives that are driving new discoveries. Whether it’s big pharma, academic research groups, TechBio companies, or some combination – a number of institutions recognize the value of collaboration and knowledge sharing and are providing open source tools,…
